Dapagliflozin is a pharmaceutical raw material used in the manufacturing of medications that inhibit sodium-glucose co-transporter 2 (SGLT-2). It is significant for its role in reducing glucose reabsorption in the kidney.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Dapagliflozin?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Dapagliflozin propanediol hydrate
pharmaceutical raw material
Bexagliflozin
pharmaceutical raw material
Sotagliflozin
pharmaceutical raw material
Β-lactulose
pharmaceutical raw material
Nutriacholic acid
pharmaceutical raw material
Plecanatide
pharmaceutical raw material
Orphenadrine citrate
pharmaceutical raw material
Dapagliflozin Impurity D
pharmaceutical intermediate
The international HS code for Dapagliflozin (CAS 461432-26-8) is 2932.99.
2932.99
2932 99 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
JVHXJTBJCFBINQ-ADAARDCZSA-N
CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl
Sourcing Dapagliflozin?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.